StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3027% below fair value
$96.43+2.52 (+2.68%)

Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%

TransMedics net income

Net income is the profit left for shareholders after every expense, interest and tax.

TransMedics's net income for the twelve months ending Jun 30, 2026 was $151.70M, up 111.7% year over year. For fiscal 2025 it was $190.29M, up 436.6% from the year before. The highest annual figure on record is $190.29M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$190.29M+436.6%
FY2024Dec 31, 2024$35.46M–
FY2023Dec 31, 2023-$25.03M–
FY2022Dec 31, 2022-$36.23M–
FY2021Dec 31, 2021-$44.22M–
FY2020Dec 31, 2020-$28.75M–
FY2019Dec 28, 2019-$33.55M–
FY2018Dec 29, 2018-$23.76M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.68M-57.9%
Q1 FY2026Mar 31, 2026$7.32M-71.5%
Q4 FY2025Dec 31, 2025$105.38M+1436.9%
Q3 FY2025Sep 30, 2025$24.32M+476.8%
Q2 FY2025Jun 30, 2025$34.91M+186.3%
Q1 FY2025Mar 31, 2025$25.68M+110.6%
Q4 FY2024Dec 31, 2024$6.86M+70.1%
Q3 FY2024Sep 30, 2024$4.22M–
Q2 FY2024Jun 30, 2024$12.19M–
Q1 FY2024Mar 31, 2024$12.20M–
Q4 FY2023Dec 31, 2023$4.03M–
Q3 FY2023Sep 30, 2023-$25.42M–
Q2 FY2023Jun 30, 2023-$1.00M–
Q1 FY2023Mar 31, 2023-$2.64M–
Q4 FY2022Dec 31, 2022-$6.72M–
Q3 FY2022Sep 30, 2022-$7.43M–
Q2 FY2022Jun 30, 2022-$11.52M–
Q1 FY2022Mar 31, 2022-$10.56M–
Q4 FY2021Dec 31, 2021-$12.67M–
Q3 FY2021Sep 30, 2021-$12.96M–
Q2 FY2021Jun 30, 2021-$10.67M–
Q1 FY2021Mar 31, 2021-$7.92M–
Q4 FY2020Dec 31, 2020-$6.31M–
Q3 FY2020Sep 30, 2020-$5.09M–
Q2 FY2020Jun 30, 2020-$8.50M–
Q1 FY2020Mar 31, 2020-$8.85M–
Q4 FY2019Dec 28, 2019-$9.18M–
Q3 FY2019Sep 28, 2019-$8.28M–
Q2 FY2019Jun 29, 2019-$9.20M–
Q1 FY2019Mar 30, 2019-$6.90M–
Q4 FY2018Dec 29, 2018-$7.64M–
Q3 FY2018Sep 29, 2018-$5.11M–
Q2 FY2018Jun 30, 2018-$6.12M–
Q1 FY2018Mar 31, 2018-$4.90M–

More TransMedics figures

See a number that looks wrong?